Summit Investment Advisors Inc. Sells 338 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Summit Investment Advisors Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,261 shares of the healthcare conglomerate’s stock after selling 338 shares during the quarter. Summit Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $8,732,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $341,000. Principal Financial Group Inc. grew its stake in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. M&T Bank Corp raised its stake in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. McIlrath & Eck LLC grew its position in UnitedHealth Group by 8.2% in the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate’s stock worth $371,000 after purchasing an additional 48 shares during the last quarter. Finally, SOA Wealth Advisors LLC. raised its position in shares of UnitedHealth Group by 3.7% during the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate’s stock valued at $746,000 after buying an additional 46 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by corporate insiders.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Truist Financial upped their price target on UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a report on Friday. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Twenty-one equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $632.85.

UnitedHealth Group Stock Performance

UNH stock opened at $599.10 on Friday. The stock has a market capitalization of $548.00 billion, a PE ratio of 38.65, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a 50 day moving average price of $512.87 and a 200 day moving average price of $542.03. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the business earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.40%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.